Vanderbilt Kennedy Center — Nashville, Tennessee

Vanderbilt Kennedy Center is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Vanderbilt Kennedy Center has participated in 12 clinical trials with 1 currently active.

Therapeutic areas: Autism Spectrum Disorder, Rett Syndrome, Rett Syndrome, Atypical.

Sponsors: Vanderbilt University, International Rett Syndrome Foundation, Seaside Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Kennedy Center?

Vanderbilt Kennedy Center has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Kennedy Center conducted?

Vanderbilt Kennedy Center has 12 clinical trials on record, with 1 currently active. Their work covers Autism Spectrum Disorder, Rett Syndrome, Rett Syndrome, Atypical.

Is Vanderbilt Kennedy Center accredited by Crixeo Health?

Yes — Vanderbilt Kennedy Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Vanderbilt Kennedy Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.